HealthEquity, Inc. $HQY Shares Sold by Aristotle Capital Boston LLC

Aristotle Capital Boston LLC reduced its stake in HealthEquity, Inc. (NASDAQ:HQY) by 1.6% during the 3rd quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 436,034 shares of the company’s stock after selling 7,291 shares during the period. HealthEquity makes up approximately 2.1% of Aristotle Capital Boston LLC’s portfolio, making the stock its 4th biggest position. Aristotle Capital Boston LLC’s holdings in HealthEquity were worth $41,323,000 as of its most recent filing with the Securities and Exchange Commission.

Other large investors also recently bought and sold shares of the company. Xponance Inc. increased its position in shares of HealthEquity by 0.8% during the third quarter. Xponance Inc. now owns 12,265 shares of the company’s stock valued at $1,162,000 after acquiring an additional 102 shares during the last quarter. Advisors Asset Management Inc. raised its stake in shares of HealthEquity by 4.7% in the 2nd quarter. Advisors Asset Management Inc. now owns 2,437 shares of the company’s stock valued at $255,000 after acquiring an additional 110 shares during the period. Fiduciary Trust Co lifted its holdings in shares of HealthEquity by 3.4% in the 3rd quarter. Fiduciary Trust Co now owns 3,669 shares of the company’s stock worth $348,000 after acquiring an additional 120 shares during the last quarter. Coldstream Capital Management Inc. lifted its holdings in shares of HealthEquity by 7.3% in the 2nd quarter. Coldstream Capital Management Inc. now owns 2,027 shares of the company’s stock worth $212,000 after acquiring an additional 138 shares during the last quarter. Finally, Farther Finance Advisors LLC lifted its holdings in shares of HealthEquity by 59.3% in the 3rd quarter. Farther Finance Advisors LLC now owns 392 shares of the company’s stock worth $37,000 after acquiring an additional 146 shares during the last quarter. Institutional investors and hedge funds own 99.55% of the company’s stock.

HealthEquity Price Performance

Shares of HQY opened at $77.81 on Friday. The company has a market cap of $6.65 billion, a P/E ratio of 35.69, a PEG ratio of 0.97 and a beta of 0.26. HealthEquity, Inc. has a fifty-two week low of $72.76 and a fifty-two week high of $116.65. The company has a quick ratio of 4.13, a current ratio of 4.13 and a debt-to-equity ratio of 0.46. The firm’s 50 day moving average price is $81.91 and its 200 day moving average price is $90.39.

Wall Street Analysts Forecast Growth

HQY has been the subject of several research reports. Barclays dropped their target price on shares of HealthEquity from $118.00 to $110.00 and set an “overweight” rating for the company in a report on Wednesday, February 18th. JPMorgan Chase & Co. upped their price target on HealthEquity from $126.00 to $129.00 and gave the stock an “overweight” rating in a research note on Thursday, December 4th. BMO Capital Markets set a $85.00 price target on HealthEquity in a research report on Tuesday, February 24th. UBS Group set a $110.00 price objective on HealthEquity in a research note on Tuesday, February 17th. Finally, Raymond James Financial set a $100.00 target price on HealthEquity in a research note on Tuesday, February 17th. One equities research analyst has rated the stock with a Strong Buy rating, eleven have issued a Buy rating, two have given a Hold rating and one has given a Sell rating to the stock. Based on data from MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and an average target price of $112.00.

Insider Buying and Selling at HealthEquity

In related news, EVP Elimelech Rosner sold 10,959 shares of HealthEquity stock in a transaction on Thursday, December 18th. The stock was sold at an average price of $95.45, for a total value of $1,046,036.55. Following the completion of the transaction, the executive vice president directly owned 45,742 shares in the company, valued at approximately $4,366,073.90. This trade represents a 19.33% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Also, EVP Delano Ladd sold 1,500 shares of the business’s stock in a transaction on Friday, December 19th. The stock was sold at an average price of $94.72, for a total value of $142,080.00. Following the transaction, the executive vice president directly owned 73,979 shares of the company’s stock, valued at $7,007,290.88. The trade was a 1.99% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. Insiders own 1.50% of the company’s stock.

About HealthEquity

HealthEquity, Inc (NASDAQ: HQY) is a leading administrator of consumer-directed health accounts and related benefit solutions in the United States. Founded in 2002 and headquartered in Draper, Utah, the company specializes in health savings accounts (HSAs) and offers complementary services such as flexible spending accounts (FSAs), health reimbursement arrangements (HRAs), COBRA administration and commuter benefits. Through its technology-driven platform, HealthEquity enables employers, health plans and individuals to streamline account management, improve cost transparency and encourage more informed healthcare spending.

Serving millions of members across all 50 states, HealthEquity leverages an open-architecture ecosystem that integrates with health plans, payroll providers and financial institutions.